#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema IPEX syndrome T-cell lymphoma Univentricular heart Neonatal asphyxia Laryngeal squamous cell carcinoma Rectal cancer Undifferentiated sarcoma Hyperinsulinism Nephrotic syndrome Hodgkin's disease recurrent Antithrombin III deficiency Retinal artery occlusion Leiomyosarcoma recurrent Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Basic Information Cytokine release syndrome – Life with Disease Advanced systemic mastocytosis – Life with Disease Cystic fibrosis lung Idiopathic pulmonary fibrosis Hereditary optic atrophy – Diagnostics Angelman’s syndrome – Basic Information CADASIL – Treatment Pleural mesothelioma malignant Nephrotic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcifediol Neflamapimod Pelareorep Entinostat ZAMPILIMAB Sodium Sulfate Anhydrous Cefepime Chloropyramine Hydrochloride Ulipristal Acetate Immunoglobulin A Benztropine Mesylate Bempedoic Acid Etidronate Disodium GRNA-001 Ceftriaxone Sodium Lebrikizumab Fexofenadine Tipiracil A49 Efavirenz More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis III Thromboangiitis obliterans Acarodermatitis Aortic disorder Vertigo Langerhans cell sarcoma Biliary tract disorder Conjunctivitis allergic Cardiac failure Medulloblastoma recurrent Malignant melanoma stage III Atrial flutter Neonatal hyperglycaemia Venous thrombosis Endometrial cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Tolerability of ODM-212 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Odm-212
    Finland France Spain

  • Study on Omega-3 Fatty Acids for Reducing Organ Failure and Mortality in Patients with Severe Acute Pancreatitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatitis acute
    Investigated Drugs:
    • Glycerol
    • Highly Refined Fish Oil
    • Purified Egg Phospholipids
    Denmark The Netherlands

  • Study on Gene Therapy GNT0003 for Patients with Severe Crigler-Najjar Syndrome Requiring Phototherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crigler-Najjar syndrome
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2/8 Containing The Human Ugt1A1 Gene
    • Tolu Balsam
    • Sirolimus
    France Italy The Netherlands

  • Study on Palonosetron and Netupitant for Preventing Nausea in Endometrial Cancer Patients Undergoing Taxane-Platinum Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Netupitant
    • Dexamethasone Phosphate
    • Palonosetron
    Italy

  • Study on Stopping CDK4/6 Inhibitors in Patients with Metastatic HR Positive, HER2 Negative Breast Cancer Using Abemaciclib, Letrozole, and Fulvestrant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Abemaciclib
    • Anastrozole
    • Exemestane
    Germany

  • Study on Reducing or Stopping Immunosuppression with Tacrolimus and Ciclosporin in Patients with Late Kidney Transplant Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Ciclosporin
    • Tacrolimus
    Spain
Previous Page
1 … 547 548 549 550 551 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!